Chemical screening for bioactive substances in culture media of microalgae and cyanobacteria from marine and brackish water habitats: First results

Pharmaceutical Biology

Volumn 44, Issue 7, 2006, Pages 544-549

  Scholz, Bettina ^a   Liebezeit, Gerd ^a  

^a Forschungszentrum Terramare   (Germany)

Author keywords

Alkaloids; Cyanobacteria; Flavonoids; Microalgae; Phenolic compounds; Phytochemical screening; Saponins; Tannins

Indexed keywords

FERRIC CHLORIDE; FLAVONOID; GELATIN; PHENOL; SAPONIN DERIVATIVE; SODIUM CHLORIDE; TANNIN;

ALGA; ALGAL CELL CULTURE; ARTICLE; BACTERIUM CULTURE; COLOR; CULTURE MEDIUM; CYANOBACTERIUM; DRUG SCREENING; MARINE ENVIRONMENT; NONHUMAN; PHYTOCHEMISTRY;

CYANOBACTERIA;

EID: 33750075027     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.1080/13880200600883114     Document Type: Article

References (27)

1. Admiraal W, Peletier H, Laane RWPM (1986): Nitrogen metabolism of marine planktonic diatoms; excretion, assimilation and cellular pools of free amino acids in seven species with different cell size. J Exp Marine Biol Ecol 98: 241-263.
2. Anderson GC, Zeutschel RP (1970): Release of dissolved organic matter by marine phytoplankton in coastal and offshore areas of the northeast Pacific Ocean. Limnol Oceanog 15: 402-407.
3. Apt KE, Behrens PW (1999): Commercial developments in microalgal biotechnology. J Phycol 35: 215-226.
4. Burja AM, Banaigs B, Abou-Mansour E, Burgess GJ, Wright PC (2001): Marine cyanobacteria - a prolific source of natural products. Tetrahedron 57: 9347-9377.
5. Borowitzka AM (1995): Microalgae as sources of pharmaceuticals and other biologically active compounds. J Appl Phycol 7: 3-15.
6. Gleason F, Holmgren A (1981): Isolation and characterization of thioredoxin from the cyanobacterium, Anabaena spec. J Biol Chem 256: 8306-8309.
7. Hama T, Yanagi K (2001): Production and neutral aldose compositions of dissolved carbohydrates excreted by natural marine phytoplankton populations. Limnol Oceanog 46: 1945-1955.
8. Hall S, Strichartz G, Moczydlowski E, Ravindran A, Reichardt PB (1990): The saxitoxins: Sources, chemistry, and pharmacology. In: Hall S, Strichartz G, eds., Marine Toxins: Origin, Structure and Molecular Pharmacology. Washington, DC, American Chemical Society Symposium Series No. 418, pp. 29-65.
9. Jensen LM, Solndergaard M (1985): Comparison of two methods to measure algal release of dissolved organic carbon and the subsequent uptake by bacteria. J Plankton Res 7: 41-56.
10. Konishi M, Yang X, Li B, Fairchild RC, Shimizu Y (2004): Highly cytotoxic metabolites from the culture supernatant of the temperate dinoflagellate Protoceratium cf. reticulatum. J Nat Prod 67: 1309-1313.
11. Lellau T, Liebezeit G (2001): Alkaloids, saponins and phenolic compounds in salt marsh plants from the Lower Saxonian Wadden Sea. Senckenbergia Maritima 31: 1-9.
12. Lemasson L, Pagès J, (1981): Excretion of dissolved organic phosphorus in tropical brackish waters. Estuarine, Coastal Shelf Science 12: 511-523.
13. Liebezeit G (2005): Aquaculture of "non-food organisms" for natural substances production. In: Le Gal Y, Ulber R, eds., Marine Biotechnology II, Advances in Biochemical Engineering/Biotechnology, Vol. 97. Heidelberg, Springer, pp. 1-28.
14. Luesch H, Harrigan GG, Goetz GH, Horgen FD (2002): The cyanobacterial origin of potent anticancer agents originally isolated from sa hares. Curr Med Chem 9(20): 1791-1806.
15. Moore RE, Patterson GML, Carmichael WW (1988): New pharmaceuticals from cultured blue-green algae. In: Fauntin DG, ed., Biomedical Importance of Marine Organisms-Memoirs of the Californian Academy of Science, Vol. 13. San Francisco, Californian Academy of Science, pp. 143-150.
16. Parrish CC, Bodennec G, Gentien P (1994): Time courses of intracellular and extracellular lipid classes in batch cultures of the toxic dinoflagellate, Gymnodinium cf. nagasakiense. Marine Chem 48: 71-82.
17. Patterson GML, Baldwin CL, Bolis CM, Caplan FR, Karuso H, Larsen LK, Levine IA, Moore RE, Nelson CS, Tschappat KD, Tuang GD (1991): Antineoplastic activity of cultured blue-green algae (CYANOPHYTA). J Phycol 27: 530-536.
18. Piccardi R, Frosini A, Tredici MR, Margheri MC (2000): Bioactivity in free-living and symbiotic cyanobacteria of the genus Nostoc. J Appl Phycol 12: 543-547.
19. Pujo-Pay M, Conan P, Raimbault P (1997): Excretion of dissolved organic nitrogen by phytoplankton assessed by wet oxidation and super(15)N tracer procedures. Marine Ecology-Progress Series 153: 99-111.
20. Sano T, He J, Liu Y, Kaya K (1998): Isolation of bioactive compounds in cyanobacteria from Chinese fresh water. Phycolog Res 46: 13-17.
21. Sharp JH (1977): Excretion of organic matter by phytoplankton: Do healty cells do it? Limnol Oceanog 22: 381-399.
22. Shimizu Y (2000): Microalgae as a drug source. In: Fusetani N, ed., Drugs from the Sea. Basel, Karger, pp. 30-45.
23. Skulberg OM (2000): Microalgae as a source of bioactive molecules-experience from cyanophyte research. J Appl Phycol 12: 341-348.
24. Thomas JP (1971): Release of dissolved organic matter from natural populations of marine phytoplankton. Marine Biol 11: 311-323.
25. Twiner MJ, Dixon SJ, Trick CG (2004): Extracellular organics from specific cultures of Heterosigma akashiwo (Raphidophyceae) irreversibly alter respiratory activity in mammalian cells. Harmful Algae 3: 173-182.
26. Wiebe WJ, Smith DF (1977): Direct measurement of dissolved organic carbon release by phytoplankton and incorporation by mocroheterotrophs. Marine Biol 42: 213-223.
27. Williams PJL, Yentsch CS (1976): An examiniation of photosynthetic production, excretion of photosynthetic products, and hetrotrophic utilization of dissolved organic compounds with reference to results from a subtropical sea. Marine Biol 35: 31-40.